Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXJ7NQ
|
||||
| Drug Name |
N-((S)-4-methyl-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-1-oxopentan-2-yl)furan-2-carboxamide
|
||||
| Synonyms |
CHEMBL1807649
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C23H30N4O6S
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)c1occc1)C(=O)N[C@H]2CC[C@@H](C)N(CC2=O)S(=O)(=O)c3ccccn3
|
||||
| InChI |
InChI=1S/C23H30N4O6S/c1-15(2)13-18(26-23(30)20-7-6-12-33-20)22(29)25-17-10-9-16(3)27(14-19(17)28)34(31,32)21-8-4-5-11-24-21/h4-8,11-12,15-18H,9-10,13-14H2,1-3H3,(H,25,29)(H,26,30)/t16-,17+,18+/m1/s1
|
||||
| InChIKey |
JOBQWEVUTRQKOK-SQNIBIBYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.